hcasmc Search Results


95
PromoCell vascular smooth muscle cells vsmcs
Effect of high glucose on exosomal MALAT1 expression in cultured macrophages <t>and</t> <t>vascular</t> smooth muscle cells <t>(VSMCs).</t> ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.
Vascular Smooth Muscle Cells Vsmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vascular smooth muscle cells vsmcs/product/PromoCell
Average 95 stars, based on 1 article reviews
vascular smooth muscle cells vsmcs - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Cell Applications Inc human coronary artery smooth muscle
Effect of high glucose on exosomal MALAT1 expression in cultured macrophages <t>and</t> <t>vascular</t> smooth muscle cells <t>(VSMCs).</t> ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.
Human Coronary Artery Smooth Muscle, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human coronary artery smooth muscle/product/Cell Applications Inc
Average 93 stars, based on 1 article reviews
human coronary artery smooth muscle - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Cell Applications Inc primary human coronary artery smooth muscle cells
Effect of high glucose on exosomal MALAT1 expression in cultured macrophages <t>and</t> <t>vascular</t> smooth muscle cells <t>(VSMCs).</t> ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.
Primary Human Coronary Artery Smooth Muscle Cells, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human coronary artery smooth muscle cells/product/Cell Applications Inc
Average 93 stars, based on 1 article reviews
primary human coronary artery smooth muscle cells - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell primary human coronary artery vsmcs
Effect of high glucose on exosomal MALAT1 expression in cultured macrophages <t>and</t> <t>vascular</t> smooth muscle cells <t>(VSMCs).</t> ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.
Primary Human Coronary Artery Vsmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human coronary artery vsmcs/product/PromoCell
Average 93 stars, based on 1 article reviews
primary human coronary artery vsmcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
PromoCell primary human coronary artery smooth muscle cells casmcs
Effect of high glucose on exosomal MALAT1 expression in cultured macrophages <t>and</t> <t>vascular</t> smooth muscle cells <t>(VSMCs).</t> ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.
Primary Human Coronary Artery Smooth Muscle Cells Casmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human coronary artery smooth muscle cells casmcs/product/PromoCell
Average 94 stars, based on 1 article reviews
primary human coronary artery smooth muscle cells casmcs - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
PromoCell primary human coronary artery smcs
HESC-derived epicardial cells survive and differentiate in vivo . (A-C) Fluorescent (GFP + and mStrawb + ) human epicardial cells detected in the subepicardial region at the base of the chicken heart (arrowheads). (B) Human cells in A are identifiable by bright and distinct Hoechst 33342 staining. (D-F) Fluorescent human epicardial cells detected in the subepicardial region in the middle part of the heart (arrowheads). (F) Human cells in E are identifiable by bright and distinct Hoechst 33342 staining. (G,H) Epicardial cells (GFP + ) that localised at the apex of the heart (G) expressed WT1 (H; indicated by arrowheads). (I) Co-expression of WT1 + and GFP + human cells. (J,K) A few engrafted mStrawb + epicardial cells (J) expressed ACTA2 (K), suggesting differentiation to <t>SMCs</t> in vivo . (L) Cells co-expressing mStrawb and ACTA2 (indicated by arrowheads). (M,N) GFP + and mStrawb + epicardial cells detected within lectin-stained (in cyan and <t>red)</t> <t>coronary</t> vessels. (O) Subepicardial region in a chicken embryo heart injected with mStrawb + human neural crest cells. Scale bars: 100 μm. Myo, myocardium; Epi, epicardium; Subepi, subepicardium.
Primary Human Coronary Artery Smcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human coronary artery smcs/product/PromoCell
Average 93 stars, based on 1 article reviews
primary human coronary artery smcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell smooth muscle cells hcasmcs
(A, B, C and D) Representative bright-field microscope images of stimulated, untreated HCAECs (A) and <t>HCASMCs</t> (C) compared with cytokine-stimulated (10 ng/mL of TNF-α and IL-1α for 48 h) HCAECs (B) and HCASMCs (D) treated with 50 µg/mL oxLDL for 6 h (HCAECs) or 2h (HCASMCs) and stained with Oil red O. Droplets stained with Oil red O were observed within both cell types upon stimulation and treatment. Images were taken using a Leica© bright-field microscope and are representative of 3 independent experiments, scale bar = 100 µm. (E and F) ELISA analysis of intracellular IL-1β in HCAECs (E) and HCASMCs (F) showed a significant increase following cytokine priming but no effect with oxLDL treatment when compared to the cytokine-only control. Data are presented as mean ± s.e.m. and analysed using a one-way ANOVA followed by a Bonferroni post-hoc test, **** P < 0.0001, *** P < 0.001, n = 3 independent donors.
Smooth Muscle Cells Hcasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smooth muscle cells hcasmcs/product/PromoCell
Average 93 stars, based on 1 article reviews
smooth muscle cells hcasmcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell coronary artery ca smc
Fig. 1. RORα is expressed in different vascular <t>SMC</t> types. (A and B) RT–PCR (35 cycles) analysis of RORα and GAPDH mRNA. C-PCR and C-RT are negative controls for PCR and RT, respectively; VSMC, smooth muscle cells from saphenous veins; CASMC, <t>human</t> <t>coronary</t> artery smooth muscle cells; HASMC, human aortic smooth muscle cells. (C) RT–PCR (30 cycles) analysis of RORα mRNA in SMC infected with Ad-RORα1 or Ad-GFP for 24 h. (D) Analysis of RORα protein expression in SMC infected for 24 h with or without Ad-RORα1. Immunocytochemistry experiments were performed as previously described (Chinetti et al., 1998) using a rabbit polyclonal RORα antibody raised against aa 163–225.
Coronary Artery Ca Smc, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/coronary artery ca smc/product/PromoCell
Average 93 stars, based on 1 article reviews
coronary artery ca smc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell hcasmcs
Transcriptomic profiling of human coronary artery smooth muscle cells <t>(hCASMCs)</t> treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.
Hcasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcasmcs/product/PromoCell
Average 93 stars, based on 1 article reviews
hcasmcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell primary hcasmcs
Transcriptomic profiling of human coronary artery smooth muscle cells <t>(hCASMCs)</t> treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.
Primary Hcasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary hcasmcs/product/PromoCell
Average 93 stars, based on 1 article reviews
primary hcasmcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell human coronary artery smcs
Transcriptomic profiling of human coronary artery smooth muscle cells <t>(hCASMCs)</t> treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.
Human Coronary Artery Smcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human coronary artery smcs/product/PromoCell
Average 93 stars, based on 1 article reviews
human coronary artery smcs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
PromoCell primary human coronary artery vsmc
Transcriptomic profiling of human coronary artery smooth muscle cells <t>(hCASMCs)</t> treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.
Primary Human Coronary Artery Vsmc, supplied by PromoCell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human coronary artery vsmc/product/PromoCell
Average 93 stars, based on 1 article reviews
primary human coronary artery vsmc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Effect of high glucose on exosomal MALAT1 expression in cultured macrophages and vascular smooth muscle cells (VSMCs). ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.

Journal: Cells

Article Title: Macrophage-Derived Exosomal MALAT1 Induced by Hyperglycemia Regulates Vascular Calcification Through miR-143-3p/MGP Axis in Cultured Vascular Smooth Muscle Cells and Diabetic Rat Carotid Artery

doi: 10.3390/cells14241995

Figure Lengend Snippet: Effect of high glucose on exosomal MALAT1 expression in cultured macrophages and vascular smooth muscle cells (VSMCs). ( A ) Treatment with different glucose concentrations for 1 h. ( B ) Treatment with a glucose concentration of 25 mM for different periods of time. * p < 0.01 vs. control. ** p < 0.001 vs. control. N = 4 per group.

Article Snippet: Vascular smooth muscle cells (VSMCs) were obtained from PromoCell GmbH (Order No. c-12,511; Heidelberg, Germany).

Techniques: Expressing, Cell Culture, Concentration Assay, Control

HESC-derived epicardial cells survive and differentiate in vivo . (A-C) Fluorescent (GFP + and mStrawb + ) human epicardial cells detected in the subepicardial region at the base of the chicken heart (arrowheads). (B) Human cells in A are identifiable by bright and distinct Hoechst 33342 staining. (D-F) Fluorescent human epicardial cells detected in the subepicardial region in the middle part of the heart (arrowheads). (F) Human cells in E are identifiable by bright and distinct Hoechst 33342 staining. (G,H) Epicardial cells (GFP + ) that localised at the apex of the heart (G) expressed WT1 (H; indicated by arrowheads). (I) Co-expression of WT1 + and GFP + human cells. (J,K) A few engrafted mStrawb + epicardial cells (J) expressed ACTA2 (K), suggesting differentiation to SMCs in vivo . (L) Cells co-expressing mStrawb and ACTA2 (indicated by arrowheads). (M,N) GFP + and mStrawb + epicardial cells detected within lectin-stained (in cyan and red) coronary vessels. (O) Subepicardial region in a chicken embryo heart injected with mStrawb + human neural crest cells. Scale bars: 100 μm. Myo, myocardium; Epi, epicardium; Subepi, subepicardium.

Journal: Development (Cambridge, England)

Article Title: Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells

doi: 10.1242/dev.119271

Figure Lengend Snippet: HESC-derived epicardial cells survive and differentiate in vivo . (A-C) Fluorescent (GFP + and mStrawb + ) human epicardial cells detected in the subepicardial region at the base of the chicken heart (arrowheads). (B) Human cells in A are identifiable by bright and distinct Hoechst 33342 staining. (D-F) Fluorescent human epicardial cells detected in the subepicardial region in the middle part of the heart (arrowheads). (F) Human cells in E are identifiable by bright and distinct Hoechst 33342 staining. (G,H) Epicardial cells (GFP + ) that localised at the apex of the heart (G) expressed WT1 (H; indicated by arrowheads). (I) Co-expression of WT1 + and GFP + human cells. (J,K) A few engrafted mStrawb + epicardial cells (J) expressed ACTA2 (K), suggesting differentiation to SMCs in vivo . (L) Cells co-expressing mStrawb and ACTA2 (indicated by arrowheads). (M,N) GFP + and mStrawb + epicardial cells detected within lectin-stained (in cyan and red) coronary vessels. (O) Subepicardial region in a chicken embryo heart injected with mStrawb + human neural crest cells. Scale bars: 100 μm. Myo, myocardium; Epi, epicardium; Subepi, subepicardium.

Article Snippet: Low-passage rat aortic SMCs (RASMCs), primary human coronary artery SMCs (HCASMCs, Promocell), HeLa cells and EPI-SMCs were preloaded with the calcium-sensitive fluorophore Fluo-4 AM (2.5 μM, Molecular Probes) for 1 h at 37°C.

Techniques: Derivative Assay, In Vivo, Staining, Expressing, Injection

Epicardium-derived SMC differentiation in vitro . (A) Epithelial and mesenchymal marker expression in day 10 epicardial cells (EPI D10) and epicardium-derived SMCs (EPI-SMCs) after 3 (D3) and 6 (D6) days of differentiation with PDGF-BB and TGF-β1 (PT). *** P <0.001, ** P <0.01. (B) SMC marker expression by qRT-PCR in EPI-SMCs differentiated with PT in the presence and absence of p160 Rho-kinase inhibitor (iROCK) after 3, 6 and 12 days of differentiation. Significant differences between PT and iROCK+PT are indicated in black. *** P <0.001, ** P <0.01, * P <0.05. (C) EPI-SMCs after 12 days of PT treatment expressed mesenchymal (VIM) and SMC (ACTA2, CNN1 and TAGLN) markers, similar to human coronary artery SMCs (HCASMCs). SMC marker expression was absent in HUVECs. Scale bars: 100 μm. (D) Percentage of ACTA2 + and CNN1 + cells in H9 and BHX-derived EPI-SMCs. Mouse IgG isotypes served as negative controls.

Journal: Development (Cambridge, England)

Article Title: Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells

doi: 10.1242/dev.119271

Figure Lengend Snippet: Epicardium-derived SMC differentiation in vitro . (A) Epithelial and mesenchymal marker expression in day 10 epicardial cells (EPI D10) and epicardium-derived SMCs (EPI-SMCs) after 3 (D3) and 6 (D6) days of differentiation with PDGF-BB and TGF-β1 (PT). *** P <0.001, ** P <0.01. (B) SMC marker expression by qRT-PCR in EPI-SMCs differentiated with PT in the presence and absence of p160 Rho-kinase inhibitor (iROCK) after 3, 6 and 12 days of differentiation. Significant differences between PT and iROCK+PT are indicated in black. *** P <0.001, ** P <0.01, * P <0.05. (C) EPI-SMCs after 12 days of PT treatment expressed mesenchymal (VIM) and SMC (ACTA2, CNN1 and TAGLN) markers, similar to human coronary artery SMCs (HCASMCs). SMC marker expression was absent in HUVECs. Scale bars: 100 μm. (D) Percentage of ACTA2 + and CNN1 + cells in H9 and BHX-derived EPI-SMCs. Mouse IgG isotypes served as negative controls.

Article Snippet: Low-passage rat aortic SMCs (RASMCs), primary human coronary artery SMCs (HCASMCs, Promocell), HeLa cells and EPI-SMCs were preloaded with the calcium-sensitive fluorophore Fluo-4 AM (2.5 μM, Molecular Probes) for 1 h at 37°C.

Techniques: Derivative Assay, In Vitro, Marker, Expressing, Quantitative RT-PCR

Functional characterisation of epicardium-derived SMCs. (A) Change in the relative fluorescence unit (ΔRFU) of Fluo-4 AM-loaded HeLa cells, rat aortic SMCs (RASMC), human coronary artery (HCASMC) and epicardium-derived SMCs (EPI-SMC) by flow cytometry over 10 min after the addition of carbachol. (B) Peak ΔRFU 1 min after carbachol addition. Differences in Fluo-4 intensity compared with HeLa cells. *** P <0.001. (C) Fluo-4 AM-loaded cells displayed a change in cell surface area following carbachol stimulation. (D) EPI-SMCs, RASMCs and HCASMCs displayed 10-30% decreases in cell surface area with negligible change in HeLa cells. (E) Uptake of Alexa Fluor 594-conjugated acetylated low density lipoprotein (Ac-LDL) in EPI-SMCs and HCASMCs appears as red droplets after 2 and 3 h of incubation. Nuclei counterstained with DAPI (blue). Effective lowering of LDL uptake observed after treatment with atorvastatin (Ac-LDL+statin) in both cell types. (F) Quantification of Alexa Fluor 594 intensity in the absence (solid line) and presence (dashed line) of atorvastatin. ** P <0.01. Scale bars: 100 μm.

Journal: Development (Cambridge, England)

Article Title: Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells

doi: 10.1242/dev.119271

Figure Lengend Snippet: Functional characterisation of epicardium-derived SMCs. (A) Change in the relative fluorescence unit (ΔRFU) of Fluo-4 AM-loaded HeLa cells, rat aortic SMCs (RASMC), human coronary artery (HCASMC) and epicardium-derived SMCs (EPI-SMC) by flow cytometry over 10 min after the addition of carbachol. (B) Peak ΔRFU 1 min after carbachol addition. Differences in Fluo-4 intensity compared with HeLa cells. *** P <0.001. (C) Fluo-4 AM-loaded cells displayed a change in cell surface area following carbachol stimulation. (D) EPI-SMCs, RASMCs and HCASMCs displayed 10-30% decreases in cell surface area with negligible change in HeLa cells. (E) Uptake of Alexa Fluor 594-conjugated acetylated low density lipoprotein (Ac-LDL) in EPI-SMCs and HCASMCs appears as red droplets after 2 and 3 h of incubation. Nuclei counterstained with DAPI (blue). Effective lowering of LDL uptake observed after treatment with atorvastatin (Ac-LDL+statin) in both cell types. (F) Quantification of Alexa Fluor 594 intensity in the absence (solid line) and presence (dashed line) of atorvastatin. ** P <0.01. Scale bars: 100 μm.

Article Snippet: Low-passage rat aortic SMCs (RASMCs), primary human coronary artery SMCs (HCASMCs, Promocell), HeLa cells and EPI-SMCs were preloaded with the calcium-sensitive fluorophore Fluo-4 AM (2.5 μM, Molecular Probes) for 1 h at 37°C.

Techniques: Functional Assay, Derivative Assay, Fluorescence, Flow Cytometry, Incubation

(A, B, C and D) Representative bright-field microscope images of stimulated, untreated HCAECs (A) and HCASMCs (C) compared with cytokine-stimulated (10 ng/mL of TNF-α and IL-1α for 48 h) HCAECs (B) and HCASMCs (D) treated with 50 µg/mL oxLDL for 6 h (HCAECs) or 2h (HCASMCs) and stained with Oil red O. Droplets stained with Oil red O were observed within both cell types upon stimulation and treatment. Images were taken using a Leica© bright-field microscope and are representative of 3 independent experiments, scale bar = 100 µm. (E and F) ELISA analysis of intracellular IL-1β in HCAECs (E) and HCASMCs (F) showed a significant increase following cytokine priming but no effect with oxLDL treatment when compared to the cytokine-only control. Data are presented as mean ± s.e.m. and analysed using a one-way ANOVA followed by a Bonferroni post-hoc test, **** P < 0.0001, *** P < 0.001, n = 3 independent donors.

Journal: Vascular Biology

Article Title: OxLDL induces the release of IL-1β from primed human endothelial and smooth muscle cells via different caspase -1-dependent mechanisms

doi: 10.1530/VB-22-0009

Figure Lengend Snippet: (A, B, C and D) Representative bright-field microscope images of stimulated, untreated HCAECs (A) and HCASMCs (C) compared with cytokine-stimulated (10 ng/mL of TNF-α and IL-1α for 48 h) HCAECs (B) and HCASMCs (D) treated with 50 µg/mL oxLDL for 6 h (HCAECs) or 2h (HCASMCs) and stained with Oil red O. Droplets stained with Oil red O were observed within both cell types upon stimulation and treatment. Images were taken using a Leica© bright-field microscope and are representative of 3 independent experiments, scale bar = 100 µm. (E and F) ELISA analysis of intracellular IL-1β in HCAECs (E) and HCASMCs (F) showed a significant increase following cytokine priming but no effect with oxLDL treatment when compared to the cytokine-only control. Data are presented as mean ± s.e.m. and analysed using a one-way ANOVA followed by a Bonferroni post-hoc test, **** P < 0.0001, *** P < 0.001, n = 3 independent donors.

Article Snippet: Human coronary artery endothelial (HCAECs) and smooth muscle cells (HCASMCs) were purchased from PromoCell (Heidelberg, Germany) and maintained according to the manufacturer’s instructions.

Techniques: Microscopy, Staining, Enzyme-linked Immunosorbent Assay

(A and B) Cytokine stimulation and treatment with higher concentrations of oxLDL for 6 h (HCAECs) or 2 h (HCASMCs) induced significant IL-1β release from both HCAECs (A) and HCASMCs (B) compared to the cytokine-only control. (C and D) Increased release of IL-1β following cytokine-priming and treatment with 50 µg/mL oxLDL is associated with elevated LDH release in HCAECs (C) but not in HCASMCs (D). Samples are compared to the cytokine-only controls. Data are presented as mean ± s.e.m. and analysed using a one-way ANOVA followed by a Bonferroni post-hoc test, **** P < 0.0001, *** P < 0.001, n = 3 independent donors.

Journal: Vascular Biology

Article Title: OxLDL induces the release of IL-1β from primed human endothelial and smooth muscle cells via different caspase -1-dependent mechanisms

doi: 10.1530/VB-22-0009

Figure Lengend Snippet: (A and B) Cytokine stimulation and treatment with higher concentrations of oxLDL for 6 h (HCAECs) or 2 h (HCASMCs) induced significant IL-1β release from both HCAECs (A) and HCASMCs (B) compared to the cytokine-only control. (C and D) Increased release of IL-1β following cytokine-priming and treatment with 50 µg/mL oxLDL is associated with elevated LDH release in HCAECs (C) but not in HCASMCs (D). Samples are compared to the cytokine-only controls. Data are presented as mean ± s.e.m. and analysed using a one-way ANOVA followed by a Bonferroni post-hoc test, **** P < 0.0001, *** P < 0.001, n = 3 independent donors.

Article Snippet: Human coronary artery endothelial (HCAECs) and smooth muscle cells (HCASMCs) were purchased from PromoCell (Heidelberg, Germany) and maintained according to the manufacturer’s instructions.

Techniques:

(A and B) ELISA analysis showed a significant reduction in oxLDL-induced IL-1β release from HCAECs following inhibition of both caspase-1 (YVAD) (A) and the NLRP3 inflammasome (MCC950) (B). (C and D) The release of IL-1β from oxLDL-treated HCASMCs was only significantly reduced upon inhibition of caspase-1 (C) and not the NLRP3 inflammasome (D). Data are expressed as mean ± s.e.m. and analysed using a one-way ANOVA and a Bonferroni post-hoc test, **** P < 0.0001, n = 3 independent donors.

Journal: Vascular Biology

Article Title: OxLDL induces the release of IL-1β from primed human endothelial and smooth muscle cells via different caspase -1-dependent mechanisms

doi: 10.1530/VB-22-0009

Figure Lengend Snippet: (A and B) ELISA analysis showed a significant reduction in oxLDL-induced IL-1β release from HCAECs following inhibition of both caspase-1 (YVAD) (A) and the NLRP3 inflammasome (MCC950) (B). (C and D) The release of IL-1β from oxLDL-treated HCASMCs was only significantly reduced upon inhibition of caspase-1 (C) and not the NLRP3 inflammasome (D). Data are expressed as mean ± s.e.m. and analysed using a one-way ANOVA and a Bonferroni post-hoc test, **** P < 0.0001, n = 3 independent donors.

Article Snippet: Human coronary artery endothelial (HCAECs) and smooth muscle cells (HCASMCs) were purchased from PromoCell (Heidelberg, Germany) and maintained according to the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Inhibition

(A and B) ELISA analysis showed a significant reduction in oxLDL-induced IL-1β release from HCAECs following inhibition of gasdermin D (disulfiram) (A) but disulfiram was without effect on the release of IL-1β from HCASMCs (B). (C and D) The release of LDH was measured in HCAEC after cytokine treatment which was significantly reduced by 1 µM disulfiram treatment (C). There was no LDH release under any condition from HCASMC. Data are expressed as mean ± s.e.m. and analysed using a one-way ANOVA and a Bonferroni post-hoc test, *** P < 0.001, ** P < 0.01, n = 3 independent donors.

Journal: Vascular Biology

Article Title: OxLDL induces the release of IL-1β from primed human endothelial and smooth muscle cells via different caspase -1-dependent mechanisms

doi: 10.1530/VB-22-0009

Figure Lengend Snippet: (A and B) ELISA analysis showed a significant reduction in oxLDL-induced IL-1β release from HCAECs following inhibition of gasdermin D (disulfiram) (A) but disulfiram was without effect on the release of IL-1β from HCASMCs (B). (C and D) The release of LDH was measured in HCAEC after cytokine treatment which was significantly reduced by 1 µM disulfiram treatment (C). There was no LDH release under any condition from HCASMC. Data are expressed as mean ± s.e.m. and analysed using a one-way ANOVA and a Bonferroni post-hoc test, *** P < 0.001, ** P < 0.01, n = 3 independent donors.

Article Snippet: Human coronary artery endothelial (HCAECs) and smooth muscle cells (HCASMCs) were purchased from PromoCell (Heidelberg, Germany) and maintained according to the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Inhibition

Fig. 1. RORα is expressed in different vascular SMC types. (A and B) RT–PCR (35 cycles) analysis of RORα and GAPDH mRNA. C-PCR and C-RT are negative controls for PCR and RT, respectively; VSMC, smooth muscle cells from saphenous veins; CASMC, human coronary artery smooth muscle cells; HASMC, human aortic smooth muscle cells. (C) RT–PCR (30 cycles) analysis of RORα mRNA in SMC infected with Ad-RORα1 or Ad-GFP for 24 h. (D) Analysis of RORα protein expression in SMC infected for 24 h with or without Ad-RORα1. Immunocytochemistry experiments were performed as previously described (Chinetti et al., 1998) using a rabbit polyclonal RORα antibody raised against aa 163–225.

Journal:

Article Title: The orphan nuclear receptor ROR? is a negative regulator of the inflammatory response

doi: 10.1093/embo-reports/kve007

Figure Lengend Snippet: Fig. 1. RORα is expressed in different vascular SMC types. (A and B) RT–PCR (35 cycles) analysis of RORα and GAPDH mRNA. C-PCR and C-RT are negative controls for PCR and RT, respectively; VSMC, smooth muscle cells from saphenous veins; CASMC, human coronary artery smooth muscle cells; HASMC, human aortic smooth muscle cells. (C) RT–PCR (30 cycles) analysis of RORα mRNA in SMC infected with Ad-RORα1 or Ad-GFP for 24 h. (D) Analysis of RORα protein expression in SMC infected for 24 h with or without Ad-RORα1. Immunocytochemistry experiments were performed as previously described (Chinetti et al., 1998) using a rabbit polyclonal RORα antibody raised against aa 163–225.

Article Snippet: Primary human aortic (HA) and coronary artery (CA) SMC (PromoCell, Heidelberg, Germany) and primary SMC from saphenous veins (VSMC: a kind gift of Dr Walsh, Boston, MA) were cultured under standard conditions.

Techniques: Reverse Transcription Polymerase Chain Reaction, Infection, Expressing, Immunocytochemistry

Transcriptomic profiling of human coronary artery smooth muscle cells (hCASMCs) treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.

Journal: Physiological Genomics

Article Title: Transcriptomic sequencing reveals diverse adaptive gene expression responses of human vascular smooth muscle cells to nitro-conjugated linoleic acid

doi: 10.1152/physiolgenomics.00090.2017

Figure Lengend Snippet: Transcriptomic profiling of human coronary artery smooth muscle cells (hCASMCs) treated by nitro-conjugated linoleic acid (NO2-CLA). A: Venn diagram of differentially expressed genes (DEGs) identified in NO2-CLA vs. conjugated linoleic acid (CLA) and NO2-CLA vs. control. B: pairwise volcano plot of gene expression differences between conditions. The threshold of DEGs is defined at false discovery rate (FDR) > 0.05, and 1.3 fold up- (red) or down- (green) regulated upon treatment.

Article Snippet: hCASMCs were purchased from PromoCell (Germany) and cultured in Smooth Muscle Cell Growth Medium 2 from same company at 37°C, 5% CO 2 in a standard cell culture incubator.

Techniques: Expressing

Differentially expressed genes (DEGs) in NO2-CLA-treated hCASMCs. A: heat map of 578 DEGs expression levels. Color bar denotes the row-scaled fragments per kilobase of transcript per million mapped reads (FPKM) value, representing the Z score of gene expression across samples. B: correlation matrix of 12 samples constructed based on DEGs. C: plot of the 1st and 2nd principal component by principal component analysis (PCA) of sample variations.

Journal: Physiological Genomics

Article Title: Transcriptomic sequencing reveals diverse adaptive gene expression responses of human vascular smooth muscle cells to nitro-conjugated linoleic acid

doi: 10.1152/physiolgenomics.00090.2017

Figure Lengend Snippet: Differentially expressed genes (DEGs) in NO2-CLA-treated hCASMCs. A: heat map of 578 DEGs expression levels. Color bar denotes the row-scaled fragments per kilobase of transcript per million mapped reads (FPKM) value, representing the Z score of gene expression across samples. B: correlation matrix of 12 samples constructed based on DEGs. C: plot of the 1st and 2nd principal component by principal component analysis (PCA) of sample variations.

Article Snippet: hCASMCs were purchased from PromoCell (Germany) and cultured in Smooth Muscle Cell Growth Medium 2 from same company at 37°C, 5% CO 2 in a standard cell culture incubator.

Techniques: Expressing, Construct